50 Stocks Moving In Friday's Mid-Day Session

Gainers

• Sonoma Pharmaceuticals, Inc. SNOA shares jumped 208.5% to $16.69. Sonoma Pharmaceuticals and MicroSafe Group disclosed that Nanocyn disinfectant & sanitizer has received approval to be entered into the Australian Register of Therapeutic Goods for use against coronavirus.
• Adaptimmune Therapeutics plc ADAP shares climbed 104.3% to $9.93 after the company announced updated data from its ADP-A2M4 Phase 1 trial at the American Society for Clinical Oncology Annual Meeting.
• Phio Pharmaceuticals Corp. PHIO gained 77.9% to $3.9848 after the company reported positive data from in vivo studies that show strong antitumoral efficacy.
• Summit Midstream Partners, LP SMLP shares gained 37.4% to $1.47 after the company closed its acquisition of Summit Midstream Partners, LLC.
• Esports Entertainment Group, Inc. GMBL rose 25.5% to $6.80 after gaining around 28% on Thursday.
• Dynavax Technologies Corporation DVAX gained 24.8% to $6.04. Dynavax Technologies Director Hack bought 1,000,000 shares at $5 per share.
• Zscaler, Inc. ZS gained 23.3% to $93.49 after the company reported better-than-expected Q3 results.
• Jaguar Health, Inc. JAGX rose 20.7% to $0.51 after the company said that it has received notification from NIAD that its subsidiary Napo's request for testing crofelemer has been approved and that crofelemer will be tested against five different viruses, one of which is SARS-CoV-2.
• U.S. Gold Corp. USAU gained 18.4% to $9.56.
• Culp, Inc. CULP rose 18.1% to $8.02 after Stifel upgraded the stock from Hold to Buy and raised its price target from $8 to $13 per share.
• Agenus Inc. AGEN gained 16.5% to $3.355.
• Williams-Sonoma, Inc. WSM climbed 15.6% to $84.57 after the company reported better-than-expected Q1 sales.
• Altimmune, Inc. ALT rose 14.7% to $9.39.
• Repay Holdings Corporation RPAY surged 13.3% to $23.38. Repay Holding priced its public offering of 8 million shares at $20 per share.
• Embraer S.A. ERJ gained 13% to $5.86.
• Arcus Biosciences, Inc. RCUS shares rose 11.6% to $31.44.
• Glu Mobile Inc GLUU gained 10.8% to $9.60 after the company raised Q2 and FY20 bookings guidance.
• ADMA Biologics, Inc. ADMA climbed 10.8% to $3.1701.
• Gravity Co., Ltd. GRVY gained 10.1% to $46.00 after reporting Q1 results.
• Technical Communications Corporation TCCO rose 9.7% to $3.40. Technical Communications shares gained 22% on Thursday after the company reported results for its second quarter.
• VMware, Inc. VMW rose 6.8% to $152.11 after the company reported better-than-expected Q1 results.
• Dell Technologies Inc. DELL gained 6% to $48.32 after the company reported better-than-expected Q1 results.
• Marvell Technology Group Ltd. MRVL shares rose 5.9% to $31.73 after the company reported better-than-expected Q1 results and issued Q2 guidance.

Check out these big penny stock gainers and losers

Losers

• Minerva Neurosciences, Inc. NERV shares dipped 81.1% to $2.53 after the company reported results from Phase 3 Trial of Roluperidone for the treatment of negative symptoms in schizophrenia.
• ARCA biopharma, Inc. ABIO tumbled 30.6% to $13.33. ARCA biopharma shares climbed 386% on Thursday after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.
• Arvinas, Inc. ARVN fell 28.7% to $31.97 after the company reported updated data from the dose escalation portion of its Phase 1/2 clinical trial of ARV-110 in men with metastatic castration-resistant prostate cancer.
• AYRO Inc. AYRO dropped 21.5% to $3.05.
• ToughBuilt Industries, Inc. TBLT fell 21.4% to $0.8649 after the company reported the pricing of upsized $18.0 million underwritten public offering.
• Canopy Growth Corp CGC shares fell 20.5% to $17.28 following Q4 results. Canopy Growth posted a Q4 loss of C$3.72 per share, versus a year-ago loss of C$1.10 per share.
• Sky Solar Holdings, Ltd. SKYS dipped 18.6% to $3.06.
• Hudson Capital Inc. HUSN fell 18.3% to $0.5722 after jumping over 72% on Thursday.
• Triumph Group, Inc. TGI dropped 18% to $7.48. Triumph Group shares jumped 11% on Thursday after the company reported better-than-expected Q4 results.
• Harpoon Therapeutics, Inc. HARP fell 16% to $17.30. Harpoon Therapeutics presented interim Phase 1 data from ongoing dose escalation trial for PSMA-Targeting TriTAC HPN424 at ASCO20 Virtual Scientific Program.
• Nabors Industries Ltd. NBR dropped 15.4% to $38.04.
• Town Sports International Holdings, Inc. CLUB fell 15.2% to $0.8485 after surging around 32% on Thursday.
• MacroGenics, Inc. MGNX dipped 15.1% to $19.53.
• AVEO Pharmaceuticals, Inc. AVEO fell 15% to $7.83. AVEO Oncology reported that Phase 1b/2 DEDUCTIVE study of FOTIVDA in combo with IMFINZI in previously untreated metastatic hepatocellular carcinoma has advanced to the Phase 2 portion of the trial.
• Canaan Inc. CAN fell 13.8% to $2.51.
• Organogenesis Holdings Inc. ORGO tumbled 13.2% to $4.00.
• BridgeBio Pharma, Inc. BBIO dipped 13% to $30.57. BridgeBio Pharma reported that its affiliate QED will present data on oral FGFR1-3 inhibitor at the ASCO.
• FTS International, Inc. FTSI fell 12.4% to $6.30.
• Tarena International, Inc. TEDU dropped 12% to $2.18.
• Tactile Systems Technology, Inc. TCMD fell 11.7% to $46.60.
• Nine Energy Service, Inc. NINE shares slipped 10.7% to $2.01
• Cumulus Media Inc. CMLS dipped 10.5% to $5.29.
• Cognex Corporation CGNX fell 10.1% to $56.70 after the company reported cost-cutting measures including an 8% reduction in global workforce.
• DXC Technology Company DXC dropped 10% to $14.90 after the company reported worse-than-expected Q4 sales. Following earnings, JP Morgan downgraded the stock from Overweight to Neutral and lowered the price target from $25 to $17.
• Hexindai Inc. HX fell 7.3% to $1.2050. Hexindai shares jumped 171% on Thursday after the company highlighted the launch of Xiaobai Miami, a membership-based social e-commerce mobile platform.
• Remark Holdings, Inc. MARK fell 7.1% to $2.76 after the company reported fiscal year 2019 results.
• Marinus Pharmaceuticals, Inc. MRNS shares fell 6.8% to $2.62 after the company reported pricing of public offering of common stock.